| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39c3a06706e79b48ef4d7b444ec7faaf |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-224 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-36 |
| filingDate |
2005-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04dee109bfefcfb960c864a271c94c32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79b85a24fa11b30f2094368a9f4b0b77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e299b09676982ebcb56ac7f0146fed76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f098ac801a1f08a7519d77b4968a889b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38be8b4a8586128c56fe3e6feefef762 |
| publicationDate |
2008-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008009077-A1 |
| titleOfInvention |
Anti-Human Soluble Fibrin Monoclonal Antibody and Immunilogical Assay Method Using the Antibody |
| abstract |
The present invention is directed to a monoclonal antibody against a soluble fibrin, which specifically recognizes a conformation-changed site newly occurred in a C-terminal region of an Aα-chain of the soluble fibrin formed through thrombin digestion of fibrinogen. The present invention is also directed to a hybridoma which produces the antibody, an immunological assay method employing the antibody, and a method for evaluating hypercoagulability in a test sample by measuring the soluble fibrin level in the sample with the assay method. Through employment of the monoclonal antibody of the present invention, soluble fibrin on which plasmin has not acted, which reflects exclusively initial hypercoagulability, can be specifically detected. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012329986-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9429584-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8680233-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017202938-A1 |
| priorityDate |
2004-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |